CytoSorbents Corp. (CTSO)
0.6402
-0.01
(-1.34%)
USD |
NASDAQ |
Feb 20, 16:00
CytoSorbents SG&A Expense (Quarterly) : 8.61M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Delcath Systems, Inc. | 10.34M |
| Quest Diagnostics, Inc. | 504.00M |
| Danaher Corp. | 2.026B |
| Cardiac Biotech Solutions, Inc. | 0.3477M |
| Odyssey Health, Inc. | 0.3032M |